The global urinalysis market in terms of revenue was estimated to be worth $3.9 billion in 2022 and is poised to reach $5.7 billion by 2027, growing at a CAGR of 8.1% from 2022 to 2027.
Development of new diagnostic products and, government support boosting the market. Emerging economies such as India and Japan are providing lucrative opportunities for the players operating in the urinalysis market.
DOWNLOAD PDF BROCHURE: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=153479294
The consumables segment accounted for the largest share of the urinalysis market, by product segment, in 2021
Based on product, the urinalysis market is segmented into consumables and instruments. The consumables segment accounted for the largest share of the urinalysis market, mainly due to the growth of POC diagnostics products market, advancing diagnosis technologies with efficient and rapid results and increased emerging opportunities.
The pregnancy fertility tests segment accounted for the largest share of the urinalysis market, by test type segment, in 2021
Based on test type, the urinalysis market is segmented into pregnancy fertility tests, biochemical tests and sediment urinalysis. The pregnancy fertility tests segment accounted for the largest share of the urinalysis market, mainly due to the growth of public awareness about early pregnancy detection and increased RD investments in healthcare.
The diseases screening segment accounted for the largest share of the urinalysis market, by application segment, in 2021
Based on application, the urinalysis market is segmented into disease screening and pregnancy fertility tests. The disease screening segment accounted for the largest share of the urinalysis market, mainly due to the technological advancements in urine analyzers, increased focus on preventive care and increased funding for diagnostic research.
Diagnostic laboratories segment to register the highest growth rate during the forecast period
The urinalysis market is segmented into diagnostic laboratories, hospitals clinics, home care settings and research laboratories and institutes based on end user. In 2021, the diagnostic laboratories segment accounted for the largest share of the urinalysis market. The large share of this segment can mainly be attributed to the increased investment in the biotech and pharmaceutical industry, increased RD in the POC diagnostic segment.
North America is the largest regional market for urinalysis market
The global urinalysis market is segmented into five major regions—North America, Europe, the Asia Pacific, Latin America, and the Middle East Africa. North America accounted for the largest regional market for urinalysis market in 2021. The large share of North America in this market can be attributed to the government's support for research in the region, increased government funsing for the development of preventive care diagnostics.
The major players operating in urinalysis market are Siemens Healthineers AG (Germany), F. Hoffmann-La Roche Ltd. (Switzerland), Cardinal Health, Inc. (US), Abbott Laboratories (US), Danaher Corporation (US), Sysmex Corporation (Japan), Thermo Fisher Scientific, Inc. (US), Quidel Corporation (US), Becton, Dickinson and Company (US), Bio-Rad Laboratories, Inc. (US) and EKF Diagnostics (UK).
Read Full Report: https://www.marketsandmarkets.com/Market-Reports/urinalysis-systems-market-153479294.html
